Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Immunotherapy + Pembrolizumab for Head and Neck Cancer
Recruiting1 awardPhase 2
Columbus, Ohio
This trial will evaluate if two treatments and pembrolizumab can help people with head and neck cancer before surgery to reduce risk of recurrence and improve survival.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service